BridgeMD
New treatment option for Obesity
Official title Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
ClinicalTrials.gov ID: NCT05687604
What this study is testing
- What it's testing
- The study aims to find the best way to combine three health behavior changes: increasing physical activity, quitting smoking, and losing weight. It will also evaluate how well the program reaches different groups of cancer survivors.
- Who it's for
- The study is looking for cancer survivors who want to improve their health by changing risky behaviors.
- What's involved
- Participants will set goals for physical activity, smoking, and weight loss, and track their progress using an app or paper. They will also complete surveys and physical measurements at different times during the study.
- Time commitment
- The study lasts for 9 months and includes several visits for surveys and measurements, plus 12 telehealth sessions for some participants.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Northwestern Medicine patient
- Over 18 years old
- Meet at least 1 of the following 3 criteria:
- Engage in \<150 min/week of physical activity
- BMI of ≥25
You likely can't join if
- Currently in another dietary, weight loss, smoking cessation (including cessation pharmacotherapy), or physical activity treatment/intervention.
- Limited level of oral and written English or Spanish
- Cognitively impaired adults
- Prisoners
- Participants will be excluded from the physical activity and weight loss interventions (but not the smoking cessation component) for:
- Absolute contraindications to exercise (i.e., acute myocardial infarction, complete heart block, acute congestive heart failure, unstable angina...
See the full eligibility criteria
- Northwestern Medicine patient
- Over 18 years old
- Meet at least 1 of the following 3 criteria:
- Engage in \<150 min/week of physical activity
- BMI of ≥25
- Report that they currently smoke or smoked within the last year
- Diagnosed with any cancer (except non-melanoma skin)
- Ability to attend telehealth visits either via landline, cell phone, smartphone, tablet, laptop, or desktop computer
- 3 months post curative intent treatment if BMI of ≥25 or engage in \<150 min/week of physical activity
- Post curative intent treatment if they currently smoke or smoked within the last year
- Currently in another dietary, weight loss, smoking cessation (including cessation pharmacotherapy), or physical activity treatment/intervention.
- Limited level of oral and written English or Spanish
- Cognitively impaired adults
- Prisoners
- Participants will be excluded from the physical activity and weight loss interventions (but not the smoking cessation component) for:
- Absolute contraindications to exercise (i.e., acute myocardial infarction, complete heart block, acute congestive heart failure, unstable angina, uncontrolled hypertension), metastatic disease or planned elective surgery
- Pregnant or plans to become pregnant.
- Individuals engaging in the physical activity or weight loss interventions must pass pre- physical activity participation screening or obtain medical clearance
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.